[
  {
    "ts": null,
    "headline": "Can Thermo Fisher (TMO) Balance Biomanufacturing Expansion and AI Ambitions to Shape Its Long-Term Edge?",
    "summary": "Vaxcyte announced a new agreement with Thermo Fisher Scientific to provide up to US$1 billion in long-term commercial fill-finish capacity for pneumococcal conjugate vaccines at Thermo Fisher's Greenville, North Carolina facility. Thermo Fisher also entered partnerships with BenchSci to develop AI-powered research tools and with AstraZeneca’s BioVentureHub for collaborative R&D in chromatography, genomics, and proteomics. These collaborations highlight Thermo Fisher's dual focus on expanding...",
    "url": "https://finnhub.io/api/news?id=2fcb7eb09de5dff6bbfe8cc229ee01833afc9623b3037f492438e2b64a433c95",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759424301,
      "headline": "Can Thermo Fisher (TMO) Balance Biomanufacturing Expansion and AI Ambitions to Shape Its Long-Term Edge?",
      "id": 136960157,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Vaxcyte announced a new agreement with Thermo Fisher Scientific to provide up to US$1 billion in long-term commercial fill-finish capacity for pneumococcal conjugate vaccines at Thermo Fisher's Greenville, North Carolina facility. Thermo Fisher also entered partnerships with BenchSci to develop AI-powered research tools and with AstraZeneca’s BioVentureHub for collaborative R&D in chromatography, genomics, and proteomics. These collaborations highlight Thermo Fisher's dual focus on expanding...",
      "url": "https://finnhub.io/api/news?id=2fcb7eb09de5dff6bbfe8cc229ee01833afc9623b3037f492438e2b64a433c95"
    }
  },
  {
    "ts": null,
    "headline": "Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker",
    "summary": "ILMN partners with pharma leaders to advance KRAS-focused companion diagnostics through its TruSight Oncology platform.",
    "url": "https://finnhub.io/api/news?id=a078c55260b9e0fd9ac3b54aa2a138975b22ff0d3f57e3df8ffd2277a0889f91",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759410900,
      "headline": "Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker",
      "id": 136960158,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "ILMN partners with pharma leaders to advance KRAS-focused companion diagnostics through its TruSight Oncology platform.",
      "url": "https://finnhub.io/api/news?id=a078c55260b9e0fd9ac3b54aa2a138975b22ff0d3f57e3df8ffd2277a0889f91"
    }
  },
  {
    "ts": null,
    "headline": "Bernstein Reaffirms Outperform Rating on Thermo Fisher (TMO) After Investor Roadshow",
    "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the top picks for a retirement portfolio. On September 22, following talks with management, Bernstein reaffirmed its Outperform rating and $570 price target for Thermo Fisher Scientific Inc. (NYSE:TMO). Rafael Tejada, Head of Investor Relations at Thermo Fisher, took part in a non-deal roadshow in Toronto and Montreal […]",
    "url": "https://finnhub.io/api/news?id=a1125e1300ea58ddb9825271fd19f70185137e26eb44c58932dad11159b22d65",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759388129,
      "headline": "Bernstein Reaffirms Outperform Rating on Thermo Fisher (TMO) After Investor Roadshow",
      "id": 136955416,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the top picks for a retirement portfolio. On September 22, following talks with management, Bernstein reaffirmed its Outperform rating and $570 price target for Thermo Fisher Scientific Inc. (NYSE:TMO). Rafael Tejada, Head of Investor Relations at Thermo Fisher, took part in a non-deal roadshow in Toronto and Montreal […]",
      "url": "https://finnhub.io/api/news?id=a1125e1300ea58ddb9825271fd19f70185137e26eb44c58932dad11159b22d65"
    }
  }
]